Nagasaki, Japan

Tomoaki Kurosaki

This inventor holds 1 USPTO granted patent. Top assignees: Hamamatsu University School of Medicine, Kyushu University, Nagasaki University. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomoaki Kurosaki. Retrieved from https://idiyas.com/inventor/tomoaki-kurosaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomoaki Kurosaki: Innovator in Drug Delivery Systems

Introduction

Tomoaki Kurosaki is a notable inventor based in Nagasaki, Japan. He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent that enhances the efficacy of antigen and drug delivery.

Latest Patents

Kurosaki holds a patent for a "Composite body for antigen or drug delivery." This invention provides a complex that includes an antigen or drug combined with a cationic molecule, encapsulated by an anionic molecule. The delivery complex serves as a crucial component in drug delivery systems, enabling targeted delivery of various antigens and drugs to specific cells or organs. He has 1 patent to his name.

Career Highlights

Throughout his career, Tomoaki Kurosaki has worked with prestigious institutions such as Nagasaki University and Kyushu University Corporation. His work has focused on advancing the science of drug delivery, making significant strides in how medications can be effectively administered.

Collaborations

Kurosaki has collaborated with esteemed colleagues, including Hitoshi Sasaki and Takashi Kitahara. Their joint efforts have contributed to the development of innovative solutions in the field of drug delivery.

Conclusion

Tomoaki Kurosaki's work in drug delivery systems exemplifies the impact of innovation in healthcare. His contributions continue to pave the way for advancements in how drugs and antigens are delivered to patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…